Published in Ann Surg on March 01, 2008
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res (2012) 2.10
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg (2011) 1.78
Lymph nodes and survival in pancreatic neuroendocrine tumors. Arch Surg (2012) 1.55
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28
Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg (2009) 1.10
Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg (2014) 1.03
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) (2015) 0.98
Unusual, metastatic, or neuroendocrine tumor of the pancreas: a diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry. Saudi J Gastroenterol (2012) 0.94
Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol (2011) 0.94
A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol (2012) 0.94
Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia. J Gastrointest Surg (2015) 0.93
Surgical management of pancreatic neuroendocrine tumors. Surg Today (2011) 0.93
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. J Gastroenterol (2012) 0.91
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB (Oxford) (2010) 0.87
Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol (2013) 0.85
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. World J Surg (2009) 0.84
Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer. J Gastrointest Surg (2010) 0.83
Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg (2015) 0.82
Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbecks Arch Surg (2014) 0.82
Incidental intraoperative discovery of a pancreatic neuroendocrine tumor associated with chronic pancreatitis. Diagn Pathol (2012) 0.82
Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors. Chin Med J (Engl) (2015) 0.80
Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors. World J Gastroenterol (2014) 0.80
Significance of lymph node metastasis in pancreatic neuroendocrine tumor. Surg Today (2017) 0.80
"Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours. World J Surg (2014) 0.80
Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas (2014) 0.79
Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol (2011) 0.79
MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Cancer Biol Ther (2014) 0.79
Distal pancreatic resection for neuroendocrine tumors: is laparoscopic really better than open? J Gastrointest Surg (2015) 0.78
Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems. Medicine (Baltimore) (2015) 0.78
Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas. Medicine (Baltimore) (2015) 0.78
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors. Invest New Drugs (2016) 0.77
Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution. Appl Clin Inform (2010) 0.77
Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience. BMC Gastroenterol (2016) 0.77
Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas. ISRN Surg (2012) 0.77
Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review. World J Surg (2016) 0.77
Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford) (2013) 0.77
Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice. Cancer Imaging (2012) 0.77
Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center. Oncol Lett (2017) 0.75
Pancreatic neuroendocrine tumors. Intractable Rare Dis Res (2017) 0.75
Metastatic well-differentiated neuroendocrine carcinoma of the pancreas: case report and review of literature. Cases J (2009) 0.75
Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs). Medicine (Baltimore) (2015) 0.75
Breast and lung metastasis from pancreatic neuroendocrine carcinoma. World J Radiol (2011) 0.75
Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. J Oncol Pract (2011) 0.75
Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol (2016) 0.75
Alternative lengthening of telomeres in primary pancreatic neuroendocrine neoplasms is associated with aggressive clinical behavior and poor survival. Clin Cancer Res (2016) 0.75
Pancreatic Aetiology for Massive Upper Gastrointestinal Haemorrhage in Pregnancy. Case Rep Surg (2016) 0.75
National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Non-Functional Pancreatic Neuroendocrine Tumors. J Am Coll Surg (2016) 0.75
Update on surgical treatment of pancreatic neuroendocrine neoplasms. World J Gastroenterol (2014) 0.75
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2004) 10.61
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol (2009) 4.53
Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol (2009) 4.09
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
National failure to operate on early stage pancreatic cancer. Ann Surg (2007) 3.65
Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2009) 3.55
Disparities in the utilization of high-volume hospitals for complex surgery. JAMA (2006) 3.35
Updated population-based review of carcinoid tumors. Ann Surg (2004) 3.21
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg (2009) 3.07
Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg (2009) 3.05
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 3.03
The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol (2003) 3.02
Use of radioactive iodine for thyroid cancer. JAMA (2011) 2.98
Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg (2011) 2.87
Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer (2007) 2.85
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol (2008) 2.74
A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg (2012) 2.72
The aging population and its impact on the surgery workforce. Ann Surg (2003) 2.70
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med (2012) 2.62
Effect of delay to operation on outcomes in adults with acute appendicitis. Arch Surg (2010) 2.53
Blueprint for a new American College of Surgeons: National Surgical Quality Improvement Program. J Am Coll Surg (2008) 2.53
Patterns of surgical care of lung cancer patients. Ann Thorac Surg (2005) 2.51
Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst (2008) 2.46
A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum (2005) 2.45
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg (2013) 2.37
Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA (2013) 2.31
Rates of colon and rectal cancers are increasing in young adults. Am Surg (2003) 2.30
Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat (2009) 2.25
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol (2008) 2.20
Do young colon cancer patients have worse outcomes? World J Surg (2004) 2.20
Validity and feasibility of the american college of surgeons colectomy composite outcome quality measure. Ann Surg (2013) 2.18
Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am (2006) 2.15
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol (2008) 2.15
Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg (2010) 2.14
Does aggressive local therapy improve survival in metastatic breast cancer? Surgery (2002) 2.13
Risk adjustment for comparing hospital quality with surgery: how many variables are needed? J Am Coll Surg (2010) 2.12
The influence of resident involvement on surgical outcomes. J Am Coll Surg (2011) 2.12
Hospitalization before and after gastric bypass surgery. JAMA (2005) 2.12
Use and outcomes of laparoscopic-assisted colectomy for cancer in the United States. Arch Surg (2008) 2.10
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer (2008) 2.09
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol (2012) 2.08
Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin (2002) 2.07
Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg (2007) 2.04
Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw (2011) 2.03
Malignancies of the appendix: beyond case series reports. Dis Colon Rectum (2005) 2.02
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
Adherence with postdischarge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly Medicare beneficiaries. Ann Surg (2014) 1.97
The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol (2004) 1.94
Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg (2012) 1.94
Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst (2009) 1.92
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol (2009) 1.90
Reliability of superficial surgical site infections as a hospital quality measure. J Am Coll Surg (2011) 1.90
Association between occurrence of a postoperative complication and readmission: implications for quality improvement and cost savings. Ann Surg (2013) 1.87
Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg (2012) 1.86
Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg (2006) 1.84
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg (2013) 1.84
Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch Surg (2009) 1.83
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg (2009) 1.83
Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2008) 1.82